Current Approaches to Skin Cancer Management in Organ Transplant Recipients

Meena K. Singh, Jerry D. Brewer

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Approximately 225,000 people are living with organ transplants in the United States. Organ transplant recipients have a greater risk of developing skin cancer, including basal cell carcinoma, squamous cell carcinoma, and malignant melanoma, with an approximately 250 times greater incidence of squamous cell carcinoma in certain transplant recipients, compared with the general population. Because skin cancers are the most common posttransplant malignancy, the resultant morbidity and mortality in these high-risk patients is quite significant.

Original languageEnglish (US)
Pages (from-to)35-47
Number of pages13
JournalSeminars in Cutaneous Medicine and Surgery
Volume30
Issue number1
DOIs
StatePublished - Mar 2011

Fingerprint

Skin Neoplasms
Squamous Cell Carcinoma
Transplants
Basal Cell Carcinoma
Melanoma
Morbidity
Mortality
Incidence
Population
Neoplasms
Transplant Recipients

ASJC Scopus subject areas

  • Dermatology
  • Surgery

Cite this

Current Approaches to Skin Cancer Management in Organ Transplant Recipients. / Singh, Meena K.; Brewer, Jerry D.

In: Seminars in Cutaneous Medicine and Surgery, Vol. 30, No. 1, 03.2011, p. 35-47.

Research output: Contribution to journalArticle

Singh, Meena K. ; Brewer, Jerry D. / Current Approaches to Skin Cancer Management in Organ Transplant Recipients. In: Seminars in Cutaneous Medicine and Surgery. 2011 ; Vol. 30, No. 1. pp. 35-47.
@article{4369cbb66ef8466d9704d39143618ca7,
title = "Current Approaches to Skin Cancer Management in Organ Transplant Recipients",
abstract = "Approximately 225,000 people are living with organ transplants in the United States. Organ transplant recipients have a greater risk of developing skin cancer, including basal cell carcinoma, squamous cell carcinoma, and malignant melanoma, with an approximately 250 times greater incidence of squamous cell carcinoma in certain transplant recipients, compared with the general population. Because skin cancers are the most common posttransplant malignancy, the resultant morbidity and mortality in these high-risk patients is quite significant.",
author = "Singh, {Meena K.} and Brewer, {Jerry D.}",
year = "2011",
month = "3",
doi = "10.1016/j.sder.2011.02.003",
language = "English (US)",
volume = "30",
pages = "35--47",
journal = "Seminars in Cutaneous Medicine and Surgery",
issn = "1085-5629",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Current Approaches to Skin Cancer Management in Organ Transplant Recipients

AU - Singh, Meena K.

AU - Brewer, Jerry D.

PY - 2011/3

Y1 - 2011/3

N2 - Approximately 225,000 people are living with organ transplants in the United States. Organ transplant recipients have a greater risk of developing skin cancer, including basal cell carcinoma, squamous cell carcinoma, and malignant melanoma, with an approximately 250 times greater incidence of squamous cell carcinoma in certain transplant recipients, compared with the general population. Because skin cancers are the most common posttransplant malignancy, the resultant morbidity and mortality in these high-risk patients is quite significant.

AB - Approximately 225,000 people are living with organ transplants in the United States. Organ transplant recipients have a greater risk of developing skin cancer, including basal cell carcinoma, squamous cell carcinoma, and malignant melanoma, with an approximately 250 times greater incidence of squamous cell carcinoma in certain transplant recipients, compared with the general population. Because skin cancers are the most common posttransplant malignancy, the resultant morbidity and mortality in these high-risk patients is quite significant.

UR - http://www.scopus.com/inward/record.url?scp=79955431214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955431214&partnerID=8YFLogxK

U2 - 10.1016/j.sder.2011.02.003

DO - 10.1016/j.sder.2011.02.003

M3 - Article

VL - 30

SP - 35

EP - 47

JO - Seminars in Cutaneous Medicine and Surgery

JF - Seminars in Cutaneous Medicine and Surgery

SN - 1085-5629

IS - 1

ER -